Cargando…
Clinical implications of BRAF mutation test in colorectal cancer
Knowledge about the clinical significance of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) mutations in colorectal cancer (CRC) is growing. BRAF encodes a protein kinase involved with intracellular signaling and cell division. The gene product is a downstream effector of Kirsten Ras 1(KRAS)...
Autores principales: | Mojarad, Ehsan Nazemalhosseini, Farahani, Roya Kishani, Haghighi, Mahdi Montazer, Aghdaei, Hamid Asadzadeh, Kuppen, Peter JK, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Institute for Gastroenterology and Liver Diseases
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017487/ https://www.ncbi.nlm.nih.gov/pubmed/24834238 |
Ejemplares similares
-
The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013) -
The association between SMAD7 polymorphisms and colorectal cancer susceptibility as well as clinicopathological features in the Iranian population
por: Akbari, Zahra, et al.
Publicado: (2020) -
Lack of BRAFV600E mutation in stage I and II of colorectal cancer
por: Molaei, Mahsa, et al.
Publicado: (2016) -
Coexistence of KRAS and BRAF Mutations in Colorectal
Cancer: A Case Report Supporting The Concept of
Tumoral Heterogeneity
por: Larki, Pegah, et al.
Publicado: (2017) -
Different frequency of epidermal growth factor rs76189946 polymorphism genotype in an Iranian colorectal cancer
por: Chaleshi, Vahid, et al.
Publicado: (2013)